Lu B - Search Results

1

Enhanced radiation damage of tumor vasculature by mTOR inhibitors.

Shinohara ET, Cao C, Niermann K, Mu Y, Zeng F, Hallahan DE, Lu B. Shinohara ET, et al. Among authors: lu b. Oncogene. 2005 Aug 18;24(35):5414-22. doi: 10.1038/sj.onc.1208715. Oncogene. 2005. PMID: 15940265

2

Receptor tyrosine kinase inhibitors as anti-angiogenic agents.

Kim DW, Lu B, Hallahan DE. Kim DW, et al. Among authors: lu b. Curr Opin Investig Drugs. 2004 Jun;5(6):597-604. Curr Opin Investig Drugs. 2004. PMID: 15242247 Review.

3

XIAP and survivin as therapeutic targets for radiation sensitization in preclinical models of lung cancer.

Cao C, Mu Y, Hallahan DE, Lu B. Cao C, et al. Among authors: lu b. Oncogene. 2004 Sep 16;23(42):7047-52. doi: 10.1038/sj.onc.1207929. Oncogene. 2004. PMID: 15258565

4

Murine double minute 2 as a therapeutic target for radiation sensitization of lung cancer.

Cao C, Shinohara ET, Niermann KJ, Donnelly EF, Chen X, Hallahan DE, Lu B. Cao C, et al. Among authors: lu b. Mol Cancer Ther. 2005 Aug;4(8):1137-45. doi: 10.1158/1535-7163.MCT-04-0327. Mol Cancer Ther. 2005. PMID: 16093429

5

Clusterin as a therapeutic target for radiation sensitization in a lung cancer model.

Cao C, Shinohara ET, Li H, Niermann KJ, Kim KW, Sekhar KR, Gleave M, Freeman M, Lu B. Cao C, et al. Among authors: lu b. Int J Radiat Oncol Biol Phys. 2005 Nov 15;63(4):1228-36. doi: 10.1016/j.ijrobp.2005.07.956. Int J Radiat Oncol Biol Phys. 2005. PMID: 16253777

6

The use of tyrosine kinase inhibitors in modifying the response of tumor microvasculature to radiotherapy.

Lu B, Shinohara ET, Edwards E, Geng L, Tan J, Hallahan DE. Lu B, et al. Technol Cancer Res Treat. 2005 Dec;4(6):691-8. doi: 10.1177/153303460500400614. Technol Cancer Res Treat. 2005. PMID: 16292890 Free article. Review.

7

Radiosensitization of lung cancer by nutlin, an inhibitor of murine double minute 2.

Cao C, Shinohara ET, Subhawong TK, Geng L, Kim KW, Albert JM, Hallahan DE, Lu B. Cao C, et al. Among authors: lu b. Mol Cancer Ther. 2006 Feb;5(2):411-7. doi: 10.1158/1535-7163.MCT-05-0356. Mol Cancer Ther. 2006. PMID: 16505116

8

Autophagy for cancer therapy through inhibition of pro-apoptotic proteins and mammalian target of rapamycin signaling.

Kim KW, Mutter RW, Cao C, Albert JM, Freeman M, Hallahan DE, Lu B. Kim KW, et al. Among authors: lu b. J Biol Chem. 2006 Dec 1;281(48):36883-90. doi: 10.1074/jbc.M607094200. Epub 2006 Sep 27. J Biol Chem. 2006. PMID: 17005556 Free article.

9

The role of mTOR inhibition in augmenting radiation induced autophagy.

Jaboin JJ, Shinohara ET, Moretti L, Yang ES, Kaminski JM, Lu B. Jaboin JJ, et al. Among authors: lu b. Technol Cancer Res Treat. 2007 Oct;6(5):443-7. doi: 10.1177/153303460700600510. Technol Cancer Res Treat. 2007. PMID: 17877432 Free article. Review.

10

The use of gene therapy in cancer research and treatment.

Shinohara ET, Lu B, Hallahan DE. Shinohara ET, et al. Among authors: lu b. Technol Cancer Res Treat. 2004 Oct;3(5):479-90. doi: 10.1177/153303460400300509. Technol Cancer Res Treat. 2004. PMID: 15453813 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

6,646 results

Search Page